NEW YORK, July 5, 2021 /PRNewswire/ — The enzyme-linked immunosorbent assay (ELISA) testing market is expected to grow by USD 265.55 million during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the market in optimistic, probable, and pessimistic forecast scenarios.
Enterprises will go through the Response, Recovery, and Renew phases.
The enzyme-linked immunosorbent assay (ELISA) testing market will witness a neutral impact during the forecast period owing to the widespread growth of the COVID-19 pandemic. As per Technavio’s pandemic-focused market research, market growth is likely to increase in 2021 as compared to 2020.
With the continuing spread of the novel coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses will go through response, recovery, and renew phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis towards the Next Normal.
This post-pandemic business planning research will aid clients to:
- Adjust their strategic planning to move ahead once business stability kicks in.
- Build Resilience by making effective resource and investment choices for individual business units, products, and service lines.
- Conceptualize scenario-based planning to mitigate future crisis situations.
Key Considerations for Market Forecast:
- Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
- Optimistic, probable, and pessimistic scenarios for all markets as the impact of pandemic unfolds
- Pre- as well as post-COVID-19 market estimates
- Quarterly impact analysis and updates on market estimates
Gain instant access to 17,000+ market research reports by using
Related Report on Healthcare Industries:
Major Three Enzyme-linked Immunosorbent Assay (ELISA) Testing Market Participants:
In December 2019, the company announced a partnership with SomaServe Ltd. (SomaServe) for commercializing the cell delivery potential of polymer-based bionic nanoparticles.
Bio-Rad Laboratories Inc.
In April 2020, the company announced the acquisition of Celsee Inc., a company that offers consumables and instruments for isolation, detection, and analysis of single cells. In April 2020, the company announced the launch of a blood-based immunoassay kit to perform serology assay to identify antibodies for the coronavirus SARS-CoV-2.
Becton, Dickinson and Co.
In February 2020, the company announced a long-term strategic partnership agreement with Babson Diagnostics to bring laboratory-quality, small-volume blood collection to retail pharmacies. In November 2019, the company launched enhanced antimicrobial stewardship analytics capabilities.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Get report snapshot here to get detailed market share analysis of market participants during COVID-19 lockdown:
Enzyme-linked Immunosorbent Assay (ELISA) Testing Market 2021-2025: Segmentation
Enzyme-linked immunosorbent assay (ELISA) testing market is segmented as below:
- Hospitals And Diagnostic Centers
- Research Laboratories
- North America
The enzyme-linked immunosorbent assay (ELISA) testing market is driven by the growing need for frequent diagnostic testing among the aging population, rise in toxicology testing in the food industry, and increase in chronic diseases. In addition, other factors such as are expected to trigger the enzyme-linked immunosorbent assay (ELISA) testing market toward witnessing a CAGR of over about 9% during the forecast period.
Get more insights about the global trends impacting the future of enzyme-linked immunosorbent assay (ELISA) testing market, Request Free Sample @ https://www.technavio.com/talk-to-us?report=IRTNTR41149
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
View original content to download multimedia:https://www.prnewswire.com/news-releases/covid-19-impact-and-recovery-analysis–enzyme-linked-immunosorbent-assay-elisa-testing-market-2021-2025–technavio-301325226.html